COO - The Cooper Companies, Inc.
| Previous Close | 297.25 |
| Open | 296.63 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 1100 |
| Day's Range | 291.60 - 297.62 |
| 52 Week Range | 216.47 - 299.00 |
| Volume | 271,611 |
| Avg. Volume | 394,296 |
| Market Cap | 14.405B |
| Beta (3Y Monthly) | 1.07 |
| PE Ratio (TTM) | 39.91 |
| EPS (TTM) | 7.31 |
| Earnings Date | Jun 5, 2019 - Jun 10, 2019 |
| Forward Dividend & Yield | 0.06 (0.02%) |
| Ex-Dividend Date | 2019-01-18 |
| 1y Target Est | 312.50 |
- Moody's•2 days ago
Alcon Inc. -- Moody's assigns Baa2 issuer rating to Alcon; stable outlook
Moody's Investors Service has assigned a Baa2 long-term issuer rating to Alcon Inc. ("Alcon" or "the company"). This is the first time that Moody's assigned ratings to Alcon, a global manufacturer of eye care medical equipment and products which is being spun off from Novartis AG (Novartis, A1 stable).
- Zacks•2 days ago
Cooper Companies' (COO) CooperVision Gains Momentum Globally
Cooper Companies (COO) maintains its leading position in the markets of specialty lenses, supported by highly exclusive products like Biofinity and Clariti.
- GuruFocus.com•4 days ago
5 Companies Hit 52-Week Highs
As of late, multiple companies have managed to achieve yearly peaks
- PR Newswire•5 days ago
CooperVision's Innovative MiSight® 1 Day Contact Lenses Gain Momentum in Key European, Canadian and Asia-Pacific Markets
PLEASANTON, Calif., March 18, 2019 /PRNewswire/ -- Multiple new CooperVision initiatives in major world markets are providing a glimpse at the company's commitment to addressing the global myopia epidemic. Eye care professional (ECP)-focused standards development and educational programs are taking root in Australia and New Zealand. The company is seeing record enrollment among ECPs for this month's "Myopia Management – The Time to Act is Now" CPD-accredited continuing education events in Sydney, Melbourne & Brisbane.
- PR Newswire•9 days ago
CooperVision Voices Support for International Myopia Institute White Papers
PLEASANTON, Calif., March 14, 2019 /PRNewswire/ -- Affirming its role as a global leader in myopia management, CooperVision is voicing strong support for the publication of eight highly-anticipated white papers by the International Myopia Institute (IMI). Released within the past several days, the reports cover a range of topics deemed essential to advancing clinical knowledge and practice relating to stemming the expanding impact of myopia. The IMI papers are available in a special edition of Investigative Ophthalmology & Visual Science.
- Zacks•11 days ago
Here's Why Investors Should Bet on Cooper Companies (COO) Now
Cooper Companies (COO) maintains its leading position in the markets of specialty lenses. Further, the company exits first-quarter fiscal 2019 on a strong note.
- Markit•11 days ago
See what the IHS Markit Score report has to say about Cooper Companies Inc.
Cooper Companies Inc NYSE:COOView full report here! Summary * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is low for COO with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold COO had net inflows of $3.61 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- Thomson Reuters StreetEvents•12 days ago
Edited Transcript of COO earnings conference call or presentation 5-Mar-19 10:00pm GMT
Q1 2019 Cooper Companies Inc Earnings Call
- Simply Wall St.•12 days ago
What Is The Cooper Companies, Inc.’s (NYSE:COO) Share Price Doing?
Today we're going to take a look at the well-established The Cooper Companies, Inc. (NYSE:COO). The company's stock received a lot of attention from a substantial price increase on theRead More...
- Zacks•16 days ago
Cooper Companies (COO) Hits 52-Week High on Solid Prospects
Cooper Companies' (COO) revenues across CooperVision and CooperSurgery see growth.
- Zacks•16 days ago
What's in Store for Coupa Software (COUP) in Q4 Earnings?
Coupa Software (COUP) benefits from expanding customer base. Further, rising adoption of the company's platform is driving subscription services revenues and gross margin.
- Zacks•17 days ago
Cooper Companies' (COO) Q1 Earnings Beat, Revenues Rise Y/Y
Strong performance by Cooper Companies' (COO) CSI and CVI segments drove the top line in first-quarter fiscal 2019.
- Benzinga•17 days ago
Raymond James Lifts Cooper Companies Price Target After Q1 EPS Beat And Raise
Medical supplier Cooper Companies Inc (NYSE: COO ) outperformed first-quarter estimates on an operational basis, and its key account strategy should support share gains, according to Raymond James. The ...
Motley Fool•18 days agoCooper Companies Inc (COO) Q1 2019 Earnings Conference Call Transcript
COO earnings call for the period ending January 31, 2019.
- GlobeNewswire•18 days ago
The Cooper Companies Announces First Quarter 2019 Results
PLEASANTON, Calif., March 05, 2019 -- The Cooper Companies, Inc. (NYSE: COO) today announced financial results for the fiscal first quarter ended January 31, 2019. Revenue.
- ACCESSWIRE•18 days ago
Cooper Companies, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / March 5, 2019 / Cooper Companies, Inc. (NYSE: COO ) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on March 5, 2019 at 5:00 PM Eastern ...
- Investing.com•18 days ago
Stocks Moving After Hours: Ross Stores, Urban Outfitters, Cooper, Ambarella
Investing.com- These stocks were active postmarket.
- Zacks•19 days ago
Can Segmental Growth Aid Cooper Companies' (COO) Q1 Earnings?
Management at Cooper Companies (COO) expects solid contributions from CVI and CSI units.
- Zacks•22 days ago
Guidewire (GWRE) to Report Q2 Earnings: What's in Store?
Guidewire (GWRE) benefits from strong adoption of several cloud-based products.
- Zacks•25 days ago
Will R&D Focus Fuel DENTSPLY SIRONA's (XRAY) Earnings in Q4?
DENTSPLY SIRONA's (XRAY) overall growth strategy depends on product innovation and R&D focus, which is likely to drive the top line in Q4.
- Zacks•29 days ago
Weight Watchers (WTW) to Post Q4 Earnings: What's in Store?
Weight Watchers' (WTW) core Product Sales unit is expected to put up a soft show in fourth-quarter 2018.
- GlobeNewswire•last month
The Cooper Companies to Participate in the Barclays Global Healthcare Conference
PLEASANTON, Calif., Feb. 12, 2019 -- The Cooper Companies, Inc. (NYSE: COO) will participate in the Barclays Global Healthcare Conference in Miami, FL, on March 12, 2019. Brian.
- Simply Wall St.•last month
What You Must Know About The Cooper Companies, Inc.’s (NYSE:COO) Financial Strength
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Investors pursuing a solid, dependable stock investmentRead More...
- PR Newswire•2 months ago
INVO Bioscience Appoints Michael J. Campbell as COO & VP of Business Development
MEDFORD, Mass. , Feb. 4, 2019 /PRNewswire/ -- INVO Bioscience, Inc. (OTC: IVOB), developers of the INVOcell intravaginal culture (IVC) system, today announced the appointment of Michael J. Campbell as ...
